drug_name,side_effect,interacts_with,disease_name,disease_category,drug_category,product_name,company_name,clinical_trial_title,clinical_trial_start_date,clinical_trial_completion_date,clinical_trial_participants,clinical_trial_status,clinical_trial_condition,country,clinical_trial_institution,clinical_trial_address,clinical_trial_main_researcher
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan",adenocarcinoma,cancer,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan",complementary component deficiency,immunological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","igg receptor i, phagocytic, familial deficiency of",immunological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan",lupus erythematosus,connective tissue disorder,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan",lymphoma,cancer,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan",neutropenia,hematological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan",nonsmall cell lung cancer,cancer,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan",viral infection,immunological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980",cancer,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","c1q deficiency, type a",immunological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","c1q deficiency, type b",immunological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","c1s deficiency, isolated",immunological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","lupus nephritis, susceptibility to",connective tissue disorder,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","lymphoma, progression of",cancer,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","neutropenia, alloimmune neonatal",hematological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980",cancer,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
cetuximab,"headache,cough,renal failure,carcinoma","nan,nan","viral infections, recurrent",immunological,antineoplastic agents,erbitux,imclone llc,immune response on neoadjuvant therapy in non-small-cell lung cancer (nsclc),2007-01-01 00:00:00,2011-06-01 00:00:00,41.0,completed,"laryngeal neoplasms,mouth neoplasms",austria,medical university of vienna,"university hospital, internal medicine",wolfgang hilbe
denileukin diftitox,"headache,pain,dehydration,vasodilatation","nan,nan","interleukin-2 receptor, alpha chain, deficiency of",immunological,antineoplastic agents,ontak,eisai inc.,nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
denileukin diftitox,"headache,pain,dehydration,vasodilatation","nan,nan",severe combined immunodeficiency,immunological,antineoplastic agents,ontak,eisai inc.,nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
denileukin diftitox,"headache,pain,dehydration,vasodilatation","nan,nan",combined immunodeficiency,immunological,antineoplastic agents,ontak,eisai inc.,nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
denileukin diftitox,"headache,pain,dehydration,vasodilatation","nan,nan","combined immunodeficiency, x-linked, moderate, 312863",immunological,antineoplastic agents,ontak,eisai inc.,nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
denileukin diftitox,"headache,pain,dehydration,vasodilatation","nan,nan","severe combined immunodeficiency, x-linked, 300400",immunological,antineoplastic agents,ontak,eisai inc.,nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",asthma,respiratory,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
nan,"nan,nan,nan,nan","nan,nan",nan,nan,nan,nan,nan,addition of etanercept and extracorporeal photopheresis (ecp) to standard graft-versus-host disease (gvhd) prophylaxis in stem cell transplant,2009-03-01 00:00:00,2015-09-01 00:00:00,48.0,"active, not recruiting","nan,nan",united states,university of michigan cancer center,university of michigan cancer center,"john levine, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",asthma,respiratory,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",complementary component deficiency,immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",complementary component deficiency,immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",dementia,neurological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",dementia,neurological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","igg receptor i, phagocytic, familial deficiency of",immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","igg receptor i, phagocytic, familial deficiency of",immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",lupus erythematosus,connective tissue disorder,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",lupus erythematosus,connective tissue disorder,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",lymphoma,cancer,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",lymphoma,cancer,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",malaria,immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",malaria,immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",migraine,neurological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",migraine,neurological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",myocardial infarction,cardiovascular,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",myocardial infarction,cardiovascular,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",neutropenia,hematological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",neutropenia,hematological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",sepsis,immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",sepsis,immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",viral infection,immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan",viral infection,immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","asthma, susceptibility to, 600807",respiratory,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","asthma, susceptibility to, 600807",respiratory,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","c1q deficiency, type a",immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","c1q deficiency, type a",immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","c1q deficiency, type b",immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","c1q deficiency, type b",immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","c1s deficiency, isolated",immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","c1s deficiency, isolated",immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","dementia, vascular, susceptibility to",neurological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","dementia, vascular, susceptibility to",neurological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","lupus nephritis, susceptibility to",connective tissue disorder,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","lupus nephritis, susceptibility to",connective tissue disorder,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","lymphoma, progression of",cancer,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","lymphoma, progression of",cancer,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","malaria, cerebral, susceptibility to",immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","malaria, cerebral, susceptibility to",immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","migraine without aura, susceptibility to, 157300",neurological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","migraine without aura, susceptibility to, 157300",neurological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","myocardial infarction, susceptibility to",cardiovascular,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","myocardial infarction, susceptibility to",cardiovascular,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","neutropenia, alloimmune neonatal",hematological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","neutropenia, alloimmune neonatal",hematological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","septic shock, susceptibility to",immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","septic shock, susceptibility to",immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","viral infections, recurrent",immunological,antirheumatic agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
etanercept,"abdominal pain,nausea,melanoma,nan","nan,nan","viral infections, recurrent",immunological,immunomodulatory agents,enbrel,immunex corporation,can we miss pigmented lesions in psoriasis patients?,2007-09-01 00:00:00,2012-04-01 00:00:00,6.0,completed,"psoriasis,melanoma",united states,university of alabama at birmingham,uab dermatology,"boni elewski, md"
urokinase,"fever,nausea,nan,nan","nan,nan",alzheimer disease,neurological,thrombolytic agents,kinlytic,"imarx therapeutics, inc.",nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
urokinase,"fever,nausea,nan,nan","nan,nan","conjunctivitis, ligneous",ophthamological,thrombolytic agents,kinlytic,"imarx therapeutics, inc.",nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
urokinase,"fever,nausea,nan,nan","nan,nan",plasminogen deficiency,hematological,thrombolytic agents,kinlytic,"imarx therapeutics, inc.",nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
urokinase,"fever,nausea,nan,nan","nan,nan","alzheimer disease, late-onset, susceptibility to, 104300",neurological,thrombolytic agents,kinlytic,"imarx therapeutics, inc.",nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
urokinase,"fever,nausea,nan,nan","nan,nan","conjunctivitis, ligneous, 217090",ophthamological,thrombolytic agents,kinlytic,"imarx therapeutics, inc.",nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
urokinase,"fever,nausea,nan,nan","nan,nan",plasminogen tochigi disease,hematological,thrombolytic agents,kinlytic,"imarx therapeutics, inc.",nan,unknown,unknown,0.0,nan,"nan,nan",nan,nan,nan,nan
abciximab,"nan,nan,nan,nan","nan,nan",complementary component deficiency,immunological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",complementary component deficiency,immunological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",glanzmann thrombasthenia,hematological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",glanzmann thrombasthenia,hematological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","igg receptor i, phagocytic, familial deficiency of",immunological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","igg receptor i, phagocytic, familial deficiency of",immunological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",lupus erythematosus,connective tissue disorder,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",lupus erythematosus,connective tissue disorder,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",lymphoma,cancer,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",lymphoma,cancer,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",neutropenia,hematological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",neutropenia,hematological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",viral infection,immunological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan",viral infection,immunological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","c1q deficiency, type a",immunological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","c1q deficiency, type a",immunological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","c1q deficiency, type b",immunological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","c1q deficiency, type b",immunological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","c1s deficiency, isolated",immunological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","c1s deficiency, isolated",immunological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","glanzmann thrombasthenia, type b",hematological,anticoagulants,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
abciximab,"nan,nan,nan,nan","nan,nan","glanzmann thrombasthenia, type b",hematological,antiplatelet agents,reopro,eli lilly and company,efficacy study on early versus late abciximab administration during primary coronary angioplasty,2006-04-01 00:00:00,2008-12-01 00:00:00,110.0,completed,"nan,nan",italy,university of pisa,"cardiothoracic department, ospedale cisanello",prof. anna sonia petronio
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,myoxin,"gm  pharamceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,trioxin,"vertical pharmaceuticals, inc",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,cipro,"physicians total care, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,cipro,"alcon laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,cipro hc,stat rx usa,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,first dukes mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,first marys mouthwash compounding,"cutispharma, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,hydrocortisone,a-s medication solutions llc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,premier value,chain drug consortium,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,cortizone 10 poison ivy relief pads,"chattem, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",atherosclerosis,cardiovascular,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",cortisol resistance,endocrine,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",malaria,immunological,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",obesity,nutritional,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","asthma, dimished response to antileukotriene treatment in, 600807",respiratory,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","atherosclerosis, susceptibility to",cardiovascular,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","malaria, resistance to, 248310",immunological,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine","obesity, adrenal insufficiency, and red hair",nutritional,anti-inflammatory agents,family wellness hydrocortisone,family dollar services inc,low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
hydrocortisone,"nan,nan,nan,nan","salsalate,midodrine",asthma,respiratory,anti-inflammatory agents,pramosone e,"ferndale laboratories, inc.",low doses corticosteroids as adjuvant therapy for the treatment of severe h1n1 flu,2010-03-01 00:00:00,2011-12-01 00:00:00,40.0,terminated,"influenza in humans,nan",france,university of versailles,raymond poincaré hospital,djillali annane
